Notícias e Atividades da Pharming
Executivos
Veja o organograma con seus 35 executivos principais
Biografias mais buscadas da Pharming
- Fabrice Chouraqui, Executive Director and Chief Executive Officer
- Jabine Van Der Meijs, Director
- Richard Peters, Chairman of the Board
Recentes movimentos de executivos em Pharming
- Michael Levitan antes Vice President, Investor Relations and Corporate Communications, agora é Vice President, Investor Relations and Capital Markets (Notícia publicada em 19 de junho de 2026).
- Leverne Marsh, ingressou na Companhia como President, Chief Commercial Officer (Notícia publicada em 5 de fevereiro de 2026).
Criar um alerta
para seguir os movimentos de executivos da Pharming.
Biotecnologia
Pharming possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).
Popular M&A news in Biotecnologia
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado em 17 de julho de 2026).
- GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
- Clearside Biomedical has gone out of its bankruptcy protection (publicado em 15 de julho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Pharming
- Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
- Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
- Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
- Pharming Group announces results of 2026 Annual General Meeting of Shareholders
- Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
- Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
- Pharming Group to report first quarter 2026 financial results and provide business update on May 7
- Pharming Group announces the 2026 Annual General Meeting of Shareholders
- Pharming Group to participate in April investor conferences
- Pharming Group announces the filing of its 2025 Annual Report and Form 20-F
- View more press releases Close
Redes sociais sobre Pharming
- Pharming na Wikipedia, Google News e Yahoo Finance
- Pharming na LinkedIn, X (Twitter) e YouTube
